Hutch News

Stories tagged 'Peter Nelson'

Looking back at the future

A roundup of some of our favorite 2016 stories on research at Fred Hutch

Dec. 30, 2016 | By Fred Hutch News Service staff

At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.

View story >


Hutch News

Nov. 21, 2016

Stories include: world-renowned oncologist recruited to Fred Hutch, lymphoma patients in remission after experimental immunotherapy and more.

View story >


Beyond Ben Stiller's advice on PSA screening

The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened

Oct. 5, 2016 | By Diane Mapes / Fred Hutch News Service

Actor Ben Stiller wrote in a new essay that a "prostate cancer test saved my life." Two cancer experts weigh in on when (and if) men should get the controversial screening test.

View story >


Seattle Mariners GM Jerry Dipoto, broadcaster Dave Sims tour Fred Hutch

‘You learn to be resilient’: In baseball, both men found lessons to help overcome cancer diagnoses and treatment

Sept. 6, 2016 | By Bill Briggs / Fred Hutch News Service

They share a love for baseball — and a history of cancer. The thyroid cancer survivor and prostate cancer survivor tell their stories and connect over cutting-edge research at Fred Hutch.

View story >


Inherited mutations tied to advanced prostate cancer

Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk

July 6, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study shows men with metastatic prostate cancer are five times likelier to harbor inherited mutations in BRCA1/2 and other DNA-repair genes than the general population, irrespective of age or family history of prostate cancer.

View story >


Is metastatic prostate cancer tailor-made for precision oncology?

New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients

Feb. 29, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study from scientists at Fred Hutchinson Cancer Research Center and the University of Washington suggests metastatic prostate cancer may present just the pair of characteristics needed for precision oncology: Metastases from different patients varied widely in their genetic characteristics, and metastases within a single patient were remarkably similar.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.